Subscribe for great stories in your community!
The new analytical testing services laboratory opened by the Center for Breakthrough Medicines at the Discovery Labs complex in King of Prussia aims to address…
The CEO of a Radnor-based pharmaceutical company, Dr. Scott Braunstein, M.D., has made a top 25 list of Biotech CEOs for 2022, compiled…
The experimental COVID-19 pill developed by Merck, the pharmaceutical giant with sizable operations in West Point, and its partner Ridgeback Biotherapeutics, is less effective…
A new study by the Centers for Disease Control and Prevention (CDC) found the Pfizer COVID-19 vaccine to be 93 percent effective in protecting…
A COVID-19 pill created by Merck, the pharmaceutical giant with sizable operations in West Point, and Ridgeback Biotherapeutics performed well in a key study…
Several local universities are starting to enact vaccination policies for students and staff, before they can be on campus in the fall, writes Pete Bannan…
Merck, the pharmaceutical giant with sizable operations in West Point, has received another approval for its blockbuster cancer antibody Keytruda, writes Mark Terry for BioSpace…
Plymouth Meeting-based Inovio Pharmaceuticals saw its stock drop by 25 percent last week. This was after the U.S. government decided to pull its…
Merck, the pharmaceutical giant with sizable operations in West Point, has decided to discontinue the development of the experimental COVID-19 drug it acquired from…
Plymouth Meeting-based Inovio saw its stock jump after signing a collaboration and license agreement with Advaccine Biopharmaceuticals Suzhou for its COVID-19 DNA vaccine…
Blue Bell-based Pinnacle 21 is seeing demand for its services grow as companies rush to get new drugs and vaccines on the market due…
Plymouth Meeting-based Inovio Pharmaceuticals is waiting for approval from the FDA to start the next stage of trials for its COVID-19 vaccine candidate…
The Food and Drug Administration has placed a clinical hold on Plymouth Meeting-based Inovio Pharmaceuticals’ COVID-19 vaccine, writes Justin Heinze for the Yahoo…
Plymouth Meeting-based Harmony Biosciences closed a $50 million equity financing a week after receiving its first Food and Drug Administration drug approval.
One of…
Nabriva Therapeutics’ drug application for its antibiotic Xenleta recently got the approval from the Food and Drug Administration. The antibiotic treats community-acquired bacterial pneumonia…
Plymouth Meeting’s Pinnacle 21, which provides clinical data standards software and subject matter expertise to the life sciences industry, has won this year’s…
Before we send you to this site, please subscribe to our daily newsletter.
